SNX2112
SNX-2112 is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
| Catalog Number | T6305 |
| Alternative Name(s) | SNX-2112 , PF 04928473 , SNX 2112 |
| Research Area | Metabolism|||Cytoskeletal Signaling |
| Molecular Formula | C23H27F3N4O3 |
| CAS# | 908112-43-6 |
| Purity | 99.46% |
| SMILES | CC1(Cc2c(C(=O)C1)c(nn2c1cc(c(cc1)C(=O)N)N[C@H]1CC[C@@H](CC1)O)C(F)(F)F)C |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/SNX2112 |
| Additional Information | https://www.targetmol.com/datasheet/T6305 |